
FRESH Act of 2026 Explained: FDA, GRAS Reform and Industry Pushback
Companies Mentioned
Why It Matters
The act would cement a national, industry‑favored standard that could curb state‑level bans, shaping the future of food safety oversight. Its passage could either bring regulatory certainty for manufacturers or entrench a less proactive safety regime, affecting public health and market dynamics.
Key Takeaways
- •FRESH Act creates “common food ingredients” exemption based on pre‑1958 use
- •Mandatory GRAS notification and public registry replace voluntary system
- •FDA gets 90‑day review; firms have two years to remove unsafe ingredients
- •Industry coalition AFIT seeks federal preemption of state additive bans
- •Critics say act freezes limited oversight, hindering future safety reforms
Pulse Analysis
State‑level bans on food additives have accelerated in recent years, with California leading a wave of restrictions that leave manufacturers navigating a patchwork of regulations. At the same time, the FDA has faced budget cuts and staffing shortages, limiting its capacity to evaluate new ingredients promptly. This regulatory vacuum has spurred calls for a unified federal approach that can provide clarity for both producers and consumers while preserving public‑health safeguards.
The FRESH Act attempts to address those pressures by redefining “common food ingredients” based on historical consumption before 1958, effectively exempting a broad swath of substances from pre‑market approval. It also replaces the voluntary GRAS notification process with a mandatory, publicly searchable registry, and grants the agency a 90‑day window to assess safety claims, followed by a two‑year phase‑out period for any ingredient deemed unsafe. Proponents, including the FDA and the industry‑led Americans for Ingredient Transparency coalition, argue that these measures will streamline oversight, reduce legal fragmentation, and give companies a predictable regulatory environment.
Critics, however, contend that the act locks in a limited oversight model that relies on outdated usage patterns rather than modern toxicology, potentially stalling future reforms. Organizations such as the Environmental Working Group warn that pre‑empting state authority could erode consumer protections and make it harder to respond to emerging safety concerns. As the bill heads to the Energy and Commerce Subcommittee, its fate will signal whether the U.S. food safety system will move toward centralized, industry‑friendly regulation or retain the flexibility needed to adapt to new scientific evidence.
FRESH Act of 2026 explained: FDA, GRAS reform and industry pushback
Comments
Want to join the conversation?
Loading comments...